CellEDIT | CRISPR Cell Line Development Workflow

Overview | CRISPR Cell Line Engineering Workflow

Amid advancements in technology and biopharmaceutical research, cell line development has gained prominence, particularly in drug discovery processes such as pathway analysis, target validation, and disease modeling. The surge in novel therapeutics has escalated the demand for superior cell line development. To address this, researchers have increasingly adopted CRISPR/Cas complexes alongside traditional transfection methods for cell line development. Traditional approaches rely on batch transfection methods like electroporation or lipofection. However, the CellEDIT service introduces a disruptive single-cell transfection workflow that delivers precise quantities of CRISPR Cas9 Ribonucleoproteins directly into the nucleus. This targeted approach minimizes the risk of immune response activation and cytosolic degradation, thus significantly enhancing efficiency and precision compared to conventional methods.

Choose the CellEDIT Workflow for knockout cell line development